AIM ImmunoTech, Inc. (AIM)
0.4111
+0.18
(+76.67%)
USD |
NYAM |
May 27, 15:32
AIM ImmunoTech Cash from Investing (Quarterly) : -0.037M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agenus, Inc. | 68.95M |
| Curis, Inc. | 0.00 |
| Plus Therapeutics, Inc. | -8.533M |
| Windtree Therapeutics, Inc. | -0.789M |
| Halozyme Therapeutics, Inc. | -2.877M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.719M |
| Cash from Financing (Quarterly) | 5.587M |
| Free Cash Flow | -11.67M |
| Free Cash Flow Per Share (Quarterly) | -0.6329 |
| Free Cash Flow to Equity (Quarterly) | -2.432M |
| Free Cash Flow to Firm (Quarterly) | -2.45M |
| Free Cash Flow Yield | -1.10K% |